Pharmadrug Inc. Share Price OTC Markets
Stocks
LMLLF
CA71716W2040
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
09:14:54 02/06/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.008000 USD | -39.39% |
|
+8.11% | -10.11% |
| 28/05 | Pharmadrug Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 30/04 | Pharmadrug Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 13.42L 10L 8L 8L 7L 9.2Cr 13.63L 92.06L 35.98L 4.6Cr 36.2L 35.41L 15Cr | P/E 2024 |
-1.31x | P/E 2025 | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | 28.43L 20.42L 17.7L 16.58L 15.12L 19Cr 28.87L 1.95Cr 76.22L 9.75Cr 76.68L 75.02L 33Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
77.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -39.39% | ||
| 1 week | +8.11% | ||
| Current month | +26.98% | ||
| 1 month | +45.99% | ||
| 3 months | -9.09% | ||
| 6 months | +9.59% | ||
| Current year | -10.11% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.06 |
| 5 years | 0 | | 0.49 |
| 10 years | 0 | | 2.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Appleby
DFI | Director of Finance/CFO | 50 | 20/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul McClory
BRD | Director/Board Member | 82 | 20/12/2016 |
David Kideckel
CHM | Chairman | - | 27/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -39.39% | +8.11% | - | - | 10L | |
| -2.55% | +0.17% | +33.34% | +100.62% | 11TCr | |
| -2.54% | -2.12% | +60.05% | +151.81% | 5.59TCr | |
| -0.34% | -0.34% | +4.59% | +270.00% | 2.41TCr | |
| -0.78% | -0.42% | -13.12% | -14.11% | 828.07Cr | |
| -1.04% | +3.55% | -30.67% | -25.18% | 774.84Cr | |
| -0.48% | -3.46% | -11.56% | -22.27% | 669.35Cr | |
| +0.48% | +2.96% | +19.36% | +16.29% | 616.18Cr | |
| -1.41% | -4.91% | -6.07% | +19.81% | 501.14Cr | |
| -0.59% | -0.40% | -6.15% | -4.99% | 374.7Cr | |
| Average | -4.84% | +1.78% | +5.53% | +54.66% | 2.48TCr | |
| Weighted average by Cap. | -1.98% | +4.94% | +29.69% | +113.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -8L -6L -5L -5L -4L -5.44Cr -8L -54.41L -21.27L -2.72Cr -21.4L -20.93L -9.07Cr | -4L -3L -2L -2L -2L -2.63Cr -4L -26.3L -10.28L -1.32Cr -10.34L -10.12L -4.39Cr |
| Net Debt | 12.74L 9L 8L 7L 7L 8.73Cr 12.94L 87.38L 34.16L 4.37Cr 34.36L 33.61L 15Cr | 15.01L 10.78L 9L 9L 8L 10Cr 15.24L 1.03Cr 40.24L 5.15Cr 40.48L 39.6L 17Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $0.005560 | -19.42% | 9,420 |
| 07/26/07 | $0.006900 | +36.36% | 5,000 |
| 06/26/06 | $0.005060 | -41.16% | 1,40,046 |
| 05/26/05 | $0.008600 | +16.22% | 5,000 |
- Stock Market
- Stocks
- PHRX Stock
- LMLLF Stock
Select your edition
All financial news and data tailored to specific country editions
